18Th International Myeloma Workshop 2021 September 8-11, 2021
18th International Myeloma Workshop 2021 September 8-11, 2021 OAB-001 12Department of Medicine/Haematology, NUI, Overall Survival and Progression-free Survival Galway, Republic of Ireland by Treatment Duration With Daratumumab + 13CHU de Toulouse, IUCT-O, Université de Lenalidomide/Dexamethasone in Transplant- Toulouse, UPS, Service d’Hématologie, ineligible Newly Diagnosed Multiple Myeloma: Toulouse, France Phase 3 MAIA Study 14Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada Philippe Moreau1, Thierry Facon2, Shaji 15Department of Oncology, Hematology and Kumar3, Torben Plesner4, Robert Z. Orlowski5, Bone Marrow Transplantation, University Nizar Bahlis6, Supratik Basu7, Hareth Nahi8, Medical Center Hamburg-Eppendorf, Hamburg, Cyrille Hulin9, Hang Quach10, Hartmut Germany Goldschmidt11, Michael O’Dwyer12, Aurore 16Florida Cancer Specialists, St. Petersburg, FL, Perrot13, Christopher Venner14, Katja Weisel15, USA Joseph R. Mace16, Noopur Raje17, Mourad 17Massachusetts General Hospital Cancer Center Tiab18, Margaret Macro19, Laurent Frenzel20, 18CHD Vendée, La Roche sur Yon, France Xavier Leleu21, Huiling Pei22, Brenda Tromp23, 19Centre Hospitalier Universitaire (CHU) de Maria Delioukina24, Saad Z. Usmani25 Caen, Caen, France 20Department of Clinical Haematology, Hopital 1University Hospital Hôtel-Dieu Necker-Enfants Malades, Paris, France 2University of Lille, CHU Lille, Service des 21Service d'Hématologie et Thérapie Cellulaire, Maladies du Sang, Lille, France CHU and CIC Inserm 1402, Poitiers Cedex, 3Department of
[Show full text]